TwitterLinkedin

Contact Us

  • News & Events
    • News
    • Webinars
    • Events
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Working at PharmaLex
    • Your Application Process
    • Current Opportunities
  • Training
Top Bar
Search
PharmaLex Logo
MENUMENU
  • PharmaLex Logo
  • PharmaLex Logo
  • About UsAbout Us
    • About Us
    • Management Team
    • Our Milestones
    • Corporate Social Responsibility
    • What Our Clients Say About Us
  • Our Services
    • Discovery / Non-clinical
          • Go to Discovery / Non-clinical section >>

          • Strategy and Consulting

            • Development Strategy and Gap Analysis
            • Integrated Product Development
            • Market Access Strategy
            • Non-clinical Development Concept
              and Study Design
            • Scientific Advice
            • Scientific Due Diligence
            • Statistical Services
            • Toxicology Services
    • Clinical Development
          • Go to Clinical Development section >>

          • Strategy and Consulting

            • Clinical Program Development
            • Orphan Drug Designation
            • Pediatric Investigation Plan (PIP)
            • Scientific Advice
            • Statistical Services
          • Regulatory Affairs

            • Clinical Trial Applications (CTA)
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Regulatory Operations
          • Pharmacovigilance

            • Clinical Trial Safety Support
            • Pharmacovigilance Consulting
          • Quality

            • GxP Services
            • IMP Management
            • Interim / Contract QA
            • Quality Systems
            • Tech Transfer / Scale-up
            • Vendor Management and Oversight
    • Authorization / Approval
          • Go to Authorization / Approval section >>

          • Strategy and Consulting

            • Market Access
          • Regulatory Affairs

            • CMC Services
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Regulatory Operations
            • Scientific, Regulatory and Technical Writing
            • Statistical Services
          • Pharmacovigilance

            • EU QPPV / National QPPV
            • Pharmacovigilance Consulting
          • Quality

            • Commercialization Readiness
            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
            • PAI Readiness
    • Post-approval / Maintenance
          • Go to Post-approval / Maintenance section >>

          • Strategy and Consulting

            • Environmental Risk Assessment
            • Market Access
          • Regulatory Affairs

            • CMC Services
            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Mergers and Acquisitions (M&A) Transfers
            • Regulatory Operations
            • Toxicology Services
          • Pharmacovigilance

            • Audit and CAPA Management
            • EU QPPV / National QPPV
            • ICSR Management
            • Literature Screening
            • Pharmacovigilance Systems
            • Safety Writing (PSUR, RMP)
            • Signal Management
          • Quality

            • Commissioning, Qualification, and Validation (CQV)
            • Good Distribution Practice (GDP) Compliance
            • GxP Services
            • Interim / Contract QA
            • Quality Systems
            • Vendor Audit
            • Vendor Management and Oversight
          • Medical Affairs

            • Healthcare Compliance and Medical Approval
            • Medical Information
    • Program Management
          • Go to Program Management section >>

          • Program Management

            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Integrated Product Development
            • Mergers and Acquisitions (M&A) Transfers
    • Featured Expertise
          • Industry Expertise

            • Biopharmaceuticals
            • Consulting
            • Consumer Healthcare
            • Generics
            • Herbal Medicines
            • Medicinal Products
            • MedTech Services
            • Pharmaceutical
            • Veterinary Drugs
          • Service Expertise

            • ATMP / Cell and Gene Therapy
            • Brexit
            • COVID-19 Support
            • Drug Re-purposing / Value-added Medicines
            • GxP Services
            • Market Access
            • Pharmacovigilance Consulting
            • Statistical Services
            • SMARTPHLEX - technology-enabled services
  • Global ReachGlobal Reach
  • Contact usContact us
  • News & Events
    • News
    • Webinars
    • Events
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Working at PharmaLex
    • Your Application Process
    • Career Opportunities
  • Training
Home > Our Services > Regulatory Operations

Regulatory Operations

Confidence Beyond Compliance

Ensuring a smooth and effective submission process today goes beyond the old ways of eCTD publishing.

Modern Regulatory Operations is about proactively implementing efficient information management, scalable operational excellence, and innovative digital solutions like regulatory automation.

For over 15 years, we have led the way in regulatory submissions with an evolving holistic approach that includes everything from planning to embedded quality control. Of course, all of our services are complemented by state-of-the-art digital facilitation.

Whether working towards FDA submission, EMA submission or any other regulatory submission — our proven methods, extensive expertise, and open creative mindset cultivate long-term client relationships and success.

Expediating approximately 10,000 worldwide regulatory submissions in all formats every year, we continually enhances its practical experience with forward-thinking technologies. In addition to partnering with Veeva Systems and Lorenz, our proprietary SmartPHLEX platform offers tailor-made technological solutions.

As an active member of the international regulatory operations community, we regularly contributes to conferences and seminars to help guide thinking around subjects such as RIM/Regulatory Information Management, eCTD /electronic Common Technical Document submissions, and more.

Harness the industry leading perspective on global regulatory submissions. Add the unrivaled experience and invaluable insight of us to your team today.

Want to find out more?

PharmaLex. Confidence beyond compliance.

Contact us for more information

Document Processing

Even today, much regulatory information is hosted in electronic documents—primarily in MS Word or PDF formats—which are still the basis for regulatory submissions.

That means all documents must comply with the specific submission requirements of the targeted health authority, such as the FDA, EMA and others.

We offer a customizable eCTD service of high quality, fast and competitively priced document formatting solutions. These services combine the proficiency of pre-publishing experts with the efficiency of automated tools and processes.

It is never too early to focus on accuracy and adherence. We provide a full suite of document templates for ICH regions and beyond to easily ensure that all CTD/Common Technical Document formats are correct.

This template suite includes predefined heading styles, fonts, margins, table formats and more—allowing authors to focus on content rather than format. In addition, a user-friendly toolbar offers one-click functionality, a user guide, and full support services.

eCTD Laundry Services

  • Formatting documents in MS Word and PDF
  • Managing and applying templates in MS Word
  • Replacing/transferring standard text and logos in MS Word templates
  • Performing submission readiness QC and communicating/correcting findings (if applicable)
  • OCR scanning of paper documents
  • Converting documents to PDF format
  • Creating bookmarks and internal hyperlinks for each PDF document
  • Performing document-level publishing QC including internal bookmarks and hyperlinks

Full Lifecycle Submission Management

We offer Full Lifecycle Management for the submission process with flexible options for report-level publishing, compilation of major applications (IND, NDA, BLA, MAA, ANDA, DMF and more) and lifecycle maintenance.

Our regulatory affairs professionals are fluent in a variety of electronic formats, including eCTD/electronic Common Technical Document and SPL/Structured Product Labeling.
With more than 2,500 eCTD submissions published annually — our teams provide confidence and peace-of-mind to clients around the world.

We can support you with the following solutions:

Submission Planning and Tracking with Regulatory Project Management

  • End-to-end planning, coordination, and execution of major applications worldwide
  • Developing/managing timelines, facilitating meetings, planning/managing communication, accelerating deliverables, assessing/mitigating risks, executing plans
  • Completing simultaneous submissions to multiple regions with minimal document re-work

Electronic Submissions Processing, Publishing and Submission

  • Electronic publishing of high-quality regulatory submissions utilizing eCTD software
  • Providing submissions to global health authorities
  • Adhering to assigned timelines for global regulatory submissions

Regulatory Information Management

When it comes to RIM/Regulatory Information Management, we combine digital innovation with extensive experience and ingenuity.

In partnership with the highly regarded software companies, Veeva and Lorenz – we enable clients to optimize their processes, configure systems to maximize benefits, and reduce the operational challenges of validated GxP-relevant software systems.

With a deep understanding of the unique challenges and needs of our clients, our Regulatory Operations consultants are able to craft optimal processes that boost technological advantages while managing data in ways that are compliant and efficient.

All of these processes are bundled into our Regulatory Systems Governance solutions and provide a comprehensive, worry-free way for clients to navigate the Regulatory system landscape.

Of course, these services also include appropriate handling with Regulatory data standards, such as XEVMPD, IDMP/SPOR, and SPL.

We can help you:

Select and Implement A Regulatory Solution

  • Providing project management and subject matter expertise
  • Defining user requirements and supporting vendor selection
  • Offering consulting on process and configuration, based on our Best Practices
  • Supporting data normalization, migration and import
  • Supporting computer system validation acc. to 21 CFR Part and GAMP 5
  • Providing training, change management and (post) Go-Live support

Operate and Improve Your Existing Regulatory Systems and Processes

  • Supporting system and data maintenance
  • Supporting system and business administration
  • Providing change request handling, release management and continuous testing/validation activities
  • Offering operational data entry services, including XEVMPD, IDMP/SPOR, SPL
  • Enhancing process and operational excellence, based on real world experience
  • Ensuring data reconciliation and data quality measures
  • Providing audit and inspection support with appropriate queries and reports
Veeva

Regulatory Data and Submission Standards

While we have an impressive track record of supporting clients all over the globe in the transition to eCTD, as well as in complying with EMA’s XEVMPD requirements — we constantly look toward the future.

Development and progression of standards in the domain of Regulatory Affairs continues to rapidly evolve. And as eCTD is implemented in more countries, its next major version — eCTD 4.0 — is knocking at the door.

IDMP and SPL are also progressing in leaps and bounds. In fact, some promising new digital technologies require structured data formats, standardized data models and a unique and harmonized terminology.

We actively contributes to the development of new standards by engaging in industry associations and health authority working groups to help design the brave new world of IDMP, XEVMPD, eCTD v4.0, new regional eCTD (e.g. China eCTD) and other electronic submission formats (e.g. EAEU eCTD.)

Our experts remain in close contact with local consultants, covering the entire scope of Regulatory Intelligence in the field of Regulatory Data and Submission Standards.

We can support you with the following solutions:

Operational Support

  • Publishing and submission for human medicines in eCTD format for all ICH regions and observers: EU, US, Japan, Canada, Switzerland, China, and others
  • Electronic publishing and submission in any electronic formats for non-ICH regions: EAEU eCTD (EurAsian Economic Union), South Africa, Saudi Arabia and Gulf region, and others
  • Electronic publishing and submission for veterinary medicines: VNeeS, CVM eSubmitter, and others
  • Data entry and data submission for XEVMPD, IDMP, SPL, and other formats as needed

Strategic Advice and Implementation Support

  • Assessing impact of new data and submissions standards on systems, processes, and organization
  • Providing implementation guidance for new data and submission standards

Related News

SMARTRISK
SMARTRISK - risk assessment excipient tool
12th January 2021
latAM regulation for drug
Central American Regulation for Drug Products (LATAM)
18th December 2020
Covid19 -Impact on Compliance and Quality Culture
22nd September 2020

Related Resources

Thought Leadership

  • Improving the chances of EU approval
  • Successful marketing of medicinal cannabis
  • Latin America Leans Towards Greater Regulatory Harmonization
  • Spot the Difference
  • TOPRA // Regulatory Rapporteur Vol 15, No 10, October 2018
  • Digitally Transforming Pharma’s Regulatory Processes

Fact Flyers

  • Medical Devices for the Pharmaceutical Industry
  • Medical Device Regulations Transition Support
  • Veeva Vault RIM Implementation
  • Advanced Therapies - Navigating through the Regulatory Framework
  • Regulatory Submissions for Tobacco and Vape Products
  • Regulatory Affairs Application Services
  • Regulatory Compliance

Case Studies

  • Veeva Vault RIM Implementation
  • RIM-DMS Data Clean-up
  • Strategic outsourcing of mature product portfolio
  • Global CMC responsibility during portfolio integration
  • End-2-end portfolio maintenance (outsourcing) program
  • Post–M&A PharmaLex program governance
  • Post–M&A pharma infrastructure development
  • Regulatory CMC compliance reduced workload by 20-25%
  • Regulatory publishing support on request
  • Strategy and delivery of global biosimilar development program

White Papers

  • The Medical Device Regulation – Readiness for May 2021

Webinars

  • Streamline Operations with Unified RIM
  • Marketing Cannabis in European Countries
  • Risk Management of the presence of Nitrosamines in medicines
  • Emerging Markets: LATAM
  • Achieving and maintaining REG CMC Compliance
  • ISO IDMP Implementation in Europe

Infographics

  • Medical Device Regulations

Related Services

  • ANDA Withdrawals
  • Customer On-site Support
  • Drug Re-purposing / Value-added Medicines
  • Global Procedure Management
  • Health Authority / Agency Interaction
  • Healthcare Compliance and Medical Approval
  • MAA / NDA Submissions
  • Marketing and Labeling Activities
  • Scientific Due Diligence
  • Scientific, Regulatory and Technical Writing
  • SMARTCHECK
  • SMARTDECISIONS
  • SMARTPHLEX
  • SMARTTRACE
  • Supporting Rx to OTC switches
  • Tobacco and Vape Products

What our clients say

I just wanted to let you know that the recent EU Codes webinar was excellent. Rina presented a very complex and grey topic in the most clear and digestible manner – a sign of a true expert. The questions in the Q&A were sometimes a little ambiguous but Rina gave clear and relevant answers that provided real clarity.

Richard Blackwell
Medical Team Leader, Multi Tumor Franchise Roche Products Ltd

Hard working and there when you need them

Europe based large biotech
Regulatory Manager
USEFUL LINKS
  • Home
  • Contact us
  • Imprint
  • Data Protection
  • Terms and Conditions
RECENT TWEETS
Tweets by @PharmaLexGLOBAL
COVID-19 NEWSLETTER SIGN UP

SIGN UP NOW

WHAT OUR CLIENTS SAY
  • Able to explain technical details so non-experts can understand

    US based small / virtual company
    Partner
PharmaLex
©2021 PharmaLex GmbH. All rights reserved.

ISO9001:2015 LogoEnergie Audit Logo

#AskTheExpert #TogetherBEYONDCOVID19





    Select your state:

    .
    You can unsubscribe at any time at data.protection@pharmalex.com

    If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

    #TogetherBEYONDCOVID19

    We closely monitor developments and updates surrounding the current outbreak of Coronavirus Disease 2019 (COVID-19) from official sources including the World Health Organisation and are following the guidance and direction of the governments and the local authorities. We are taking this situation very seriously and our number one priority is the safety and business continuity for our customers and colleagues. As ever, we will do everything we can to ensure that services are delivered within the required time and the trusted quality PharmaLex is known for

      Please DO NOT send us event/conference information.
      We will not respond and these will be deleted immediately.





      Select your state:

      .
      You can unsubscribe at any time at
      data.protection@pharmalex.com

      If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

      Privacy Policy

      This can be specific information about signing up to the newsletter.

      Pellentesque lobortis, tellus at ultrices ullamcorper, lectus tellus consectetur lectus, id consequat leo quam quis eros. Mauris pellentesque tortor a augue pellentesque ultricies. Phasellus sit amet suscipit orci, vel dapibus ligula. Maecenas at pellentesque lectus, sit amet tristique felis. Integer fringilla risus ac neque mollis, at imperdiet lacus sodales. In vehicula orci sed vulputate interdum. Nunc sagittis non nunc eget sollicitudin.

      Maecenas a mattis erat. Phasellus cursus erat non nisl pulvinar ultricies. Aenean id fringilla libero. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Morbi in ultrices elit. Suspendisse egestas hendrerit est. Integer pellentesque nisl ut justo tempus, nec suscipit dolor luctus. Cras vestibulum elementum tincidunt.

      In compliance with the Spanish Law 15/1999, of Protection of Personal Data and in accordance with regulations approved by the Spanish RD 994/1999 inform you that your data will be part of a file located in Friedrichsdorf (Germany), whose ownership belongs to Pharmalex Spain S.L.U. The purpose of these data is the insertion in a potential job selection process. Inform the user that at any time may exercise their right of access, rectification, and deletion of data through email curriculum@pharmalex.com or to this postal address Pharmalex Spain. Coso 103, 50001 Zaragoza, Spain.